Ethical issues in funding research and development of drugs for neglected tropical diseases

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medical Ethics

• Publication date

  2009-04-30

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1136/jme.2008.027078PMID 19407037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Responsibility for Global Health

  2021cited by this paper
• Drug development for neglected diseases.

  2010cited by this paper
• Assessing the economic challenges posed by orphan drugs

  2007cited by this paper
• Patents, Biomedical Research, and Treatments: Examining Concerns, Canvassing Solutions

  2007cited by this paper
• Slum health: Diseases of neglected populations

  2007cited by this paper
• Climate Change Demands Action, Says U.K. Report

  2006cited by this paper
• Tackling Neglected Diseases Could Offer More Bang for the Buck

  2006cited by this paper
• The Millennium Development Goals: progress in Asia and the Pacific 2006.

  2006cited by this paper
• Ethics and governance of global health inequalities

  2006cited by this paper
• Health, development and the Millennium Development Goals

  2006cited by this paper
• Health care spending and use of information technology in OECD countries.

  2006cited by this paper
• Strategy and society: the link between competitive advantage and corporate social responsibility.

  2006cited by this paper
• Equity and Population Health: Toward a Broader Bioethics Agenda

  2006cited by this paper
• Montréal Statement on the Human Right to Essential Medicines

  2006cited by this paper
• HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM

  2005cited by this paper
• Worms can worsen malaria: towards a new means to roll back malaria?

  2005cited by this paper
• Cost-Containment as Part of Pharmaceutical Policy

  2005cited by this paper
• Neglected diseases of neglected populations: Thinking to reshape the determinants of health in Latin America and the Caribbean

  2005cited by this paper
• Ethical issues in funding orphan drug research and development

  2005cited by this paper
• When terrorism threatens health: how far are limitations on personal and economic liberties justified?

  2004cited by this paper
• The global burden of chronic diseases.

  2004cited by this paper
• The global burden of chronic diseases: overcoming impediments to prevention and control.

  2004cited by this paper
• Global Health and Global Health Ethics: Global health ethics: the rationale for mutual caring

  2003cited by this paper
• Yemen and the Millennium Development Goals

  2003cited by this paper
• Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic.

  2003cited by this paper
• Influx of fake drugs to Nigeria worries health experts

  2002cited by this paper
• Drug development for neglected diseases.

  2002cited by this paper
• Patents, Innovation and Access to New Pharmaceuticals

  2002cited by this paper
• Drug development for neglected diseases: a deficient market and a public-health policy failure.

  2002cited by this paper
• United Nations Millennium Declaration

  2001cited by this paper
• Helminths, human immunodeficiency virus and tuberculosis.

  2001cited by this paper
• The burden of disease among the global poor.

  1999cited by this paper
• International ethical guidelines for biomedical research involving human subjects

  1994cited by this paper
• Manuale di economia politica

  1965cited by this paper

• Centring race, deprivation, and disease severity in healthcare priority setting

  2022cites this paper
• A structural social work approach to oral health care in Nepal

  2021cites this paper
• Corporate social and environmental irresponsibilities in supply chains, contamination, and damage of intangible resources: A behavioural approach

  2021cites this paper
• Assessing the Roles and Impact of Non-state Actors in Global Governance

  2018cites this paper
• Outcomes and Explanations for Global Health Initiative Funding Trends in Relation to Maternal Health and Child Malnourishment in India

  2017cites this paper
• Contesting World Order?: Socioeconomic Rights and Global Justice Movements

  2017cites this paper
• Standards of Care in Global Health: Identifying the Right Question.

  2017cites this paper
• Neglected Tropical Diseases: A Continuing Priority and a Lurking Threat

  2017cites this paper
• EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future

  2016cites this paper
• Neglected Tropical Diseases - Sub-Saharan Africa

  2016cites this paper
• The Role of Health Systems in the Control of Neglected Tropical Diseases in Sub-Saharan Africa

  2016cites this paper
• Ebola and ethics: autopsy of a failure

  2015cites this paper
• ETHICAL ISSUES OF EXCESSIVE USE OF MEDICAL IMAGING INVESTIGATION OF PATIENTS WITH PREVIOUSLY ESTABLISHED DIAGNOSIS

  2015cites this paper
• Doenças negligenciadas e bioética: diálogo de um velho problema com uma nova área do

  2015cites this paper
• Research Funding: Ethical Aspects

  2015cites this paper
• Neglected diseases and bioethics: dialogue between an old problem and a new area of knowledge

  2015cites this paper
• Enfermedades desatendidas y bioética: diálogo de un viejo problema con una nueva área de conocimiento

  2015cites this paper
• The world turned upside down? A critical enquiry into the counter-hegemonic potential of socioeconomic praxis in global civil society

  2014cites this paper
• The new patent regime and disease priorities in India

  2013influential citation
• [Therapeutic experience in a Chagas disease center].

  2013cites this paper
• Access to medical products, vaccines, and medical technologies

  2013cites this paper
• Epidemiology of Schistosoma mansoni infection in sympatric humans and non-human primates in the Gombe ecosystem Tanzania

  2012cites this paper
• Pharmaceuticals in Southern Arizona

  2012cites this paper
• Pharmaceuticals Law Management: Assessment of Feasibility and Effectiveness of the Universally Accessible Cheaper Medicines Act of 2008

  2012cites this paper
• Farmacia galénica y medicamentos huérfanos

  2012cites this paper
• The causes and impacts of neglected tropical and zoonotic diseases: opportunities for integrated intervention strategies. Workshop summary.

  2011cites this paper
• Ethical considerations in collective health.

  2011cites this paper
• Drugs for the Neglected Disease Malaria Based on Natural Products

  2011cites this paper
• Pontuações sobre ética na saúde coletiva

  2011cites this paper
• Sustaining the vision for Millennium Development Goal 6, to halt and reverse the spread of HIV/AIDS and other infections.

  2010cites this paper
• DISCURSO DE RECEPCIÓN DEL ACADÉMICO ELECTO EXCMO. SR. DR. D. Luis Franco Vera DISCURDO DE CONTESTACIÓN DEL ACADÉMICO NUMERARIO EXCMO. SR. DR.

  2010cites this paper